Volkova OO, Shityakov SV, Kravtsov VY. Heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) as a pathogenetically significant drug target for oncology therapy (molecular docking of irinotecan and doxycycline). Патогенез. 2023;21(4):48-52. doi:10.25557/10.25557/2310-0435.2023.04.48–52